Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
01/10/2026 02:54
BRIEF-Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO Oct 1 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX:
DR CHRIS BREMER COMMENCES AS NEURIZON CEO
SERGIO DUCHINI TRANSITIONS TO NON-EXECUTIVE CHAIRMAN
Further company coverage: NUZ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility